Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

9.06
Delayed Data
As of Dec 02
 -0.07 / -0.77%
Today’s Change
5.49
Today|||52-Week Range
9.60
+15.12%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 10.00. The median estimate represents a +21.41% increase from the last price of 9.06.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.04
Sales
$63.7M
Reporting Date
Feb 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.32%
 
 
 
 
 
 
Growthannually 137.03%
 
 
 
 
 
 

Sales

Growthquarterly 4.79%
 
 
 
 
 
 
Growthannually 147.78%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.